CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner

European Journal of Immunology

Volumn 43, Issue 8, 2013, Pages 2043-2054

  Afzali, Behdad ^a   Mitchell, Peter J ^a   Edozie, Francis C ^a   Povoleri, Giovanni A M ^a   Dowson, Sophie E ^a   Demandt, Laura ^a   Walter, Gina ^a   Canavan, James B ^a   Scotta, Cristiano ^a   Menon, Bina ^a   Chana, Prabhjoat S ^b   Khamri, Wafa ^a   Kordasti, Shahram Y ^a   Heck, Susanne ^b   Grimbacher, Bodo ^c   Tree, Timothy ^a   Cope, Andrew P ^a   Taams, Leonie S ^a   Lechler, Robert I ^a   John, Susan ^a   Lombardi, Giovanna ^a   more..

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Conversion; Human; Regulatory T (Treg) cells; STAT3; Th17

Indexed keywords

CD161 ANTIGEN; CD45RA ANTIGEN; ETANERCEPT; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ALLOGENEIC RESTRICTION; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; T LYMPHOCYTE SUBPOPULATION;

CONVERSION; HUMAN; REGULATORY T (TREG) CELLS; STAT3; TH17;

ADULT; AGED; ANTIGENS, CD4; ANTIGENS, CD45; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84881527926     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243296     Document Type: Article

References (57)

1. Baecher-Allan, C. and Hafler, D. A., Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 2006. 212: 203-216.
2. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
3. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E. et al., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
4. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
5. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A. and Mauri, C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004. 200: 277-285.
6. Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M. and Tree, T. I., Defective suppressor function in CD4(+)CD25(+) T cells from patients with type 1 diabetes. Diabetes 2005. 54: 92-99.
7. Umetsu, D. T. and DeKruyff, R. H., The regulation of allergy and asthma. Immunol. Rev. 2006. 212: 238-255.
8. Tang, Q. and Bluestone, J. A., Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 2006. 212: 217-237.
9. Graca, L., Cobbold, S. P. and Waldmann, H., Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 2002. 195: 1641-1646.
10. Li, Y., Zhao, X., Cheng, D., Haga, H., Tsuruyama, T., Wood, K., Sakaguchi, S. et al., The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008. 86: 1837-1843.
11. Taflin, C., Nochy, D., Hill, G., Frouget, T., Rioux, N., Vérine, J., Bruneval, P. et al., Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function. Transplantation 2010. 89: 194-199.
12. Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T. and Roncarolo, M. G., Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 2006. 177: 8338-8347.
13. Scotta, C., Esposito, M., Fazekasova, H., Fanelli, G., Edozie, F. C., Ali, N., Xiao, F. et al., Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4+CD25+FOXP3+ Treg subpopulations. Haematologica 2013. 98: 1291-1299.
14. Tang, Q., Bluestone, J. A. and Kang, S. M., CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J. Mol. Cell Biol. 2012. 4: 11-21.
15. Sagoo, P., Lombardi, G. and Lechler, R. I., Regulatory T cells as therapeutic cells. Curr. Opin. Organ. Transplant 2008. 13: 645-653.
16. Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J. et al., First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin. Immunol. 2009. 133: 22-26.
17. O'shea, J. J. and Paul, W. E., Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010. 327: 1098-1102.
18. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
19. Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A. et al., Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 2008. 205: 1551-1557.
20. Afzali, B., Lombardi, G., Lechler, R. I. and Lord, G. M., The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007. 148: 32-46.
21. Mathur, A. N., Chang, H.-C., Zisoulis, D. G., Kapur, R., Belladonna, M. L., Kansas, G. S. and Kaplan, M. H., T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 2006. 108: 1595-1601.
22. Bending, D., De La Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B. and Cooke, A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009. 119: 565-572.
23. Lexberg, M. H., Taubner, A., Forster, A., Albrecht, I., Richter, A., Kamradt, T., Radbruch, A. et al., Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 2008. 38: 2654-2664.
24. O'Sullivan, B. J., Thomas, H. E., Pai, S., Santamaria, P., Iwakura, Y., Steptoe, R. J., Kay, T. W. H. et al., IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 2006. 176: 7278-7287.
25. Beriou, G., Costantino, C. M., Ashley, C. W., Yang, L., Kuchroo, V. K., Baecher-Allan, C. and Hafler, D. A., IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009. 113: 4240-4249.
26. Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., Van Rijssen, E., Boots, A. M. H. and Joosten, I., Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008. 112: 2340-2352.
27. Afzali, B., Mitchell, P., Lechler, R. I., John, S. and Lombardi, G., Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin. Exp. Immunol. 2010. 159: 120-130.
28. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C. et al., Stability of the regulatory T cell lineage in vivo. Science 2010. 329: 1667-1671.
29. Hovhannisyan, Z., Treatman, J., Littman, D. R. and Mayer, L., Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011. 140: 957-965.
30. Hori, S., Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 2011. 32: 295-300.
31. Peter, C., Waldmann, H. and Cobbold, S. P., mTOR signalling and metabolic regulation of T cell differentiation. Curr. Opin. Immunol. 2010. 22: 655-661.
32. Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C. et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009. 30: 899-911.
33. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B. et al., Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007. 26: 371-381.
34. McGeachy, M. J. and Cua, D. J., Th17 cell differentiation: the long and winding road. Immunity 2008. 28: 445-453.
35. Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N. et al., Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007. 448: 1058-1062.
36. Cosmi, L., De Palma, R., Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Rodolico, G. et al., Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 2008. 205: 1903-1916.
37. Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E. et al., The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007. 8: 958-966.
38. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
39. Baecher-Allan, C., Wolf, E. and Hafler, D. A., MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006. 176: 4622-4631.
40. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. and Yamaguchi, T., Regulatory T cells: how do they suppress immune responses? Int. Immunol. 2009. 21: 1105-1111.
41. Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L., Qin, F. X.-F. et al., Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008. 28: 870-880.
42. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y. and Shevach, E. M., Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 2010. 184: 3433-3441.
43. van Amelsfort, J. M., Jacobs, K. M., Bijlsma, J. W., Lafeber, F. P. and Taams, L. S., CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis. Rheum. 2004. 50: 2775-2785.
44. de Kleer, I. M., Wedderburn, L. R., Taams, L. S., Patel, A., Varsani, H., Klein, M., de Jager, W. et al., CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 2004. 172: 6435-6443.
45. Mottonen, M., Heikkinen, J., Mustonen, L., Isomaki, P., Luukkainen, R. and Lassila, O., CD4+CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 2005. 140: 360-367.
46. van Amelsfort, J. M., Jacobs, K. M., Bijlsma, J. W., Lafeber, F. P. and Taams, L. S., CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004. 50: 2775-2785.
47. Michels-van Amelsfort, J. M., Walter, G. J. and Taams, L. S., CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev. Clin. Immunol. 2011. 7: 499-514.
48. Wehrens, E. J., Mijnheer, G., Duurland, C. L., Klein, M., Meerding, J., van Loosdregt, J., de Jager, W. et al., Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 2011. 118: 3538-3548.
49. Walter, G. J., Evans, H. G., Menon, B., Gullick, N. J., Kirkham, B. W., Cope, A. P., Geissmann, F. et al., Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells. Arthritis Rheum. 2013. 65: 627-638.
50. Klatt, N. R., Estes, J. D., Sun, X., Ortiz, A. M., Barber, J. S., Harris, L. D., Cervasi, B. et al., Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012. 5: 646-657.
51. Zhou, L. L. J., Chong, M. M., Ivanov, II, Min, R., Victora, G. D., Shen, Y., Du, J. et al., TGF-β-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORγt function. Nature 2008. 453: 236-240.
52. Morton, N. M., de Groot, R. P., Cawthorne, M. A. and Emilsson, V., Interleukin-1[beta] activates a short STAT-3 isoform in clonal insulin-secreting cells. FEBS Lett. 1999. 442: 57-60.
53. Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E. and Roncarolo, M. G., Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 2006. 55: 40-49.
54. Marek-Trzonkowska, N., Mysliwiec, M., Dobyszuk, A., Grabowska, M., Techmanska, I., Juscinska, J., Wujtewicz, M. A. et al., Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 2012. 35: 1817-1820.
55. Yates, J., Rovis, F., Mitchell, P., Afzali, B., Tsang, J. Y.-S., Garin, M., Lechler, R. I. et al., The maintenance of human CD4 +CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 2007. 19: 785-799.
56. Afzali, B., Mitchell, P. J., Scotta, C., Canavan, J., Edozie, F. C., Fazekasova, H., Lord, G. M. et al., Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells. Am. J. Transplant. 2011. 11: 1734-1742.
57. Venken, K., Thewissen, M., Hellings, N., Somers, V., Hensen, K., Rummens, J. L. and Stinissen, P., A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J. Immunol. Methods 2007. 322: 1-11.